Kidney Research and Clinical Practice

A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy: Sang Youb Han, Chan-Young Jung, Sang Ho Lee et al.; Kidney Res Clin Pract. 2022;41(4):452-461. Published online May 4, 2022; DOI: https://doi.org/10.23876/j.krcp.21.146
Web of Science 3 Cited By 4; Full text PubReader ePub PDF Supplementary Material

A Case of Anti-Glomerular Basement Membrane Disease Improved by Early Plasmapheresis and Immunosuppression Therapy: Jee-Hyun Kim, M.D. Sun Jin You, M.D. Jun-Sung Park, M.D. Chang Hwa Lee, M.D. Gheun-Ho Kim, M.D. Chong Myung Kang, M.D. So Dug Lim, M.D. Jong-Ho Lee, M.D.; Korean J Nephrol. 2009;28(3):243-247.; PDF

Minimal Change Nephrotic Syndrome After Apitoxin Therapy : A Case Report: Jong O Kim, M.D. Byung Chul Shin, M.D. Hyun Lee Kim, M.D. and Jong Hoon Chung, M.D.; Korean J Nephrol. 2007;26(6):736-739.; PDF

15,097	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
20,010	C4d Puzzle in ABO-incompatible kidney transplantation
8,516	How should we treat acute kidney injury caused by renal congestion?
13,238	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
35,339	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 15	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Search